Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee

  • Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Markt vandaag Koersen Forum Premium IEX Expert
Home  /  Forum  /  BioPharma  /  Leuk , kansrijk bedrijfje

BioPharma« Terug naar discussie overzicht

Leuk , kansrijk bedrijfje

Volgen
115 Posts
Pagina: 1 2 3 4 5 6 »» | Laatste | Omlaag ↓
  2. [verwijderd] 23 januari 2006 16:05
    eFoodSafety.com, Inc. Selected the ''#1 Stock Pick of the Year'' by The KonLin Letter

    Monday January 23, 9:45 am ET
    The KonLin Letter States That ''EFSF Was Clearly Missed by Wall Street in 2005''

    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jan. 23, 2006--Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc. (OTCBB:EFSF - News), announced today that eFoodSafety.com, Inc. has been selected by The KonLin Letter as the #1 Stock Pick for 2006. The KonLin Letter reiterates its "Strong Buy" recommendation of EFSF stock.
    According to The KonLin Letter, eFoodSafety.com, Inc. has reorganized itself into a dynamo in less than a quarter, unlike any other low-priced stock followed in all of The KonLin Letter's history.

    The KonLin Letter, a 25-year-old investment advisory newsletter noted for its fundamental and technical analysis of individual stocks and market movements, does not accept compensation for its analyses of selected companies. The report includes a review of the latest developments of the Company, the Company's market position and potential advantages, along with fundamentals and statistics.

    Konrad Kuhn, publisher of The KonLin Letter, cited the following reasons for his 2006 recommendation on EFSF:

    Avian Influenza formulation for hard and porous surfaces has completed testing with 100% efficacy, while the Avian Influenza ingestible formula will soon undergo human clinical trials on Influenza Virus strains A & B - the Bush Administration in November 2005 proposed a $7.1 Billion budget to combat Avian Influenza in 2006
    Anthrax Sporicidal is 100% effective on eradicating Anthrax's surrogate organisms, Bacillus Subtilis and Clostridium Sporogenes, on hard and porous surfaces and is expected to receive EPA approval in 2006
    Cinnergen(TM)'s Direct Response Marketing Campaign is performing well with a National TV campaign underway within a $132 billion diabetes market
    Citroxin Cleaner was sold to aid and assist the clean-up in Louisiana, specifically to eradicate "black mold" in the Lake Charles, Louisiana area - EPA Registration on this product is anticipated shortly
    Talsyn(TM) CI/bid Scar Cream's sales are at pace with the Company's initial expectations capturing a share of the $4 billion scar cream market
    The KonLin Letter concurs with management that revenue growth should continue through the 3rd quarter ending January 31, 2006, while the 4th quarter ending April 30, 2006 should be when revenue growth begins to hit its stride.

    About KonLin Research & Analysis Corp.

    The KonLin Letter, www.KonLin.com, chooses low-priced stocks to analyze, with an emphasis on emerging growth and special situations poised for explosive price appreciation. The KonLin Letter has constantly been one of the leading publications on Wall Street. It has been rated one of the best performing market letters in the nation, offering a unique service that each month recommends five low-priced selections, including a featured stock of the month. EFSF was the featured stock in the month of September 2005.

    About eFoodSafety.com, Inc.

    eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and most recently became a distributor for Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes.

  7. [verwijderd] 23 januari 2006 22:59
    quote:

    Casiraghi schreef:

    beste yellowww, is inderdaad interessant. Wat denk je ervan op korte termijn. Zijn er nog belangrijke berichten die eraan gaan komen? Gaat de koers snel naar de 0,5?
    " Citroxin Cleaner was sold to aid and assist the clean-up in Louisiana, specifically to eradicate "black mold" in the Lake Charles, Louisiana area - EPA Registration on this product is anticipated shortly "

    Dus ze hopen binnenkort van de EPA toestemming te krijgen om dit product op de markt te brengen. Bovendien moeten er in januari al inkomsten uit de verkoop van een zoetmaker ( voor diabetici )komen.

    De koers heeft wel veel moeite om de 0,30 ct uit te nemen.Als dat eenmaal is gebeurd kan het snel gaan.
  8. [verwijderd] 25 januari 2006 15:07
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jan. 25, 2006--Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF - News) announced today that Cinnergen(TM), an all natural liquid nutritional supplement designed to regulate blood sugar, is now available for purchase from Drugstore.com (NASD: DSCM - News; www.drugstore.com).
    ADVERTISEMENT


    As a result of our continued Direct Response Marketing Campaign via radio and TV, Drugstore.com, with a total life-to-date customer base of approximately 6.8 million unique customers since inception, has expressed the desire to sell our product. Cinnergen(TM) is a fitting addition to the drugstore.com online store as they currently provide a convenient, private, and informative shopping experience that encourages consumers to buy products essential to healthy everyday living.

    Cinnergen(TM) is a patent pending nutritional supplement with 0 calories, 0 grams of fat, 0 carbohydrates, and 0 grams of sugar. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As the body becomes more efficient with glucose metabolism, overall health is improved.

    Drugstore.com, Inc. is a leading online provider of health, beauty, vision and pharmacy solutions through their website www.drugstore.com. Drugstore.com, Inc. has three (3) wholly-owned subsidiaries - Beauty.com, Custom Nutrition Services, Inc., and International Vision Direct Corp. Drugstore.com is partners with Amazon.com (NasdaqNM: AMZN - News), CIGNA HealthCare Companies (NYSE: CI - News), General Nutrition Companies, Inc., MSN (NasdaqNM: MSFT - News), PetCareRX, Rite-Aid Corporation (NYSE: RAD - News), to name a few.

    "Feedback from our customers has been overwhelmingly positive and Cinnergen(TM) sales continue to escalate rapidly. With Drugstore.com making Cinnergen(TM) readily available, more consumers will be provided the opportunity to purchase Cinnergen(TM) and improve the quality of their life and health," stated Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc.

    About Cinnergen(TM)

    Cinnergen(TM) (www.cinnergen.com) is a once-a-day formula made from 15 whole foods that contain no fats, carbohydrates, sugar, or calories. Cinnergen(TM) is specially formulated to promote healthy glucose metabolism and to decrease the symptoms that commonly accompany elevated blood sugar and its effects. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As a whole food complex, Cinnergen(TM) provides several key ingredients that have been proven clinically through years of research to improve digestion and utilization of sugar, which are generally deficient in a typical American diet.

  10. [verwijderd] 25 januari 2006 15:44
    Wie kent me niet. Zoals je ziet ben ik niet negatief over alle bedrijven. Versatel zat er echt niet voor de aandeelhouders , dat is wel duidelijk geworden maar nu ben ik zelfs wel positief over Versatel. Er komt nog een staartje aan.

    Volumes in EFSF zijn de laatste tijd hoog , dit bedrijf heeft de snelste herstructuering ( 1 maand ) aller tijden achter de rug. Ze moeten zich natuurlijk nog bewijzen maar juist een investering in een opstartend ( nieuw ) bedrijf kan erg rendabel zijn.
  13. [verwijderd] 27 januari 2006 15:53
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jan. 27, 2006--Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF - News) announced today that Cinnergen(TM), an all natural liquid nutritional supplement designed to regulate blood sugar, is now available for purchase at any of the Richard's Whole Foods locations, as well as their educational internet site www.richardswholefoods.com.


    Richard's Whole Foods specializes in bringing to its patrons the highest quality natural foods, supplements, and bulk foods at the lowest possible prices. Richard's Whole Foods' interest to carry Cinnergen(TM) was as a result of the overwhelming request from its patrons resulting directly from our continued Radio and TV Direct Response Marketing Campaign. Richard's Whole Foods has 10 store locations in the Sarasota, FL area.

    Cinnergen(TM) is a patent pending nutritional supplement with 0 calories, 0 grams of fat, 0 carbohydrates, and 0 grams of sugar. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As the body becomes more efficient with glucose metabolism, overall health is improved.

    "Richard's Whole Foods is a quality establishment that caters to a clientele already looking for solutions to better health and wellness - both of which they will find in our product Cinnergen(TM)," stated Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc.

    About Cinnergen(TM)

    Cinnergen(TM) (www.cinnergen.com) is a once-a-day formula made from 15 whole foods that contain no fats, carbohydrates, sugar, or calories. Cinnergen(TM) is specially formulated to promote healthy glucose metabolism and to decrease the symptoms that commonly accompany elevated blood sugar and its effects. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As a whole food complex, Cinnergen(TM) provides several key ingredients that have been proven clinically through years of research to improve digestion and utilization of sugar, which are generally deficient in a typical American diet.

115 Posts
Pagina: 1 2 3 4 5 6 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
Kendrion 13,280 +0,62 +4,90%
Aegon 5,536 +0,18 +3,36%
AZERION 1,460 +0,05 +3,25%
Accsys 0,650 +0,02 +3,01%
ASR Nederland 44,560 +1,17 +2,70%
JDE PEET'S 20,960 +0,52 +2,54%
Sif Holding 12,600 +0,30 +2,44%
PostNL 1,250 +0,03 +2,38%
Air France-KLM 8,256 +0,17 +2,13%
SIGNIFY NV 21,560 +0,42 +1,99%
EBUSCO HOLDING 1,010 +0,02 +1,92%
FASTNED 15,900 +0,28 +1,79%
NN Group 45,050 +0,75 +1,69%
ABN AMRO BANK N.V. 15,545 +0,26 +1,67%
JUST EAT TAKEAWAY 12,835 +0,21 +1,66%
CTP 16,460 +0,26 +1,60%
Aperam 24,180 +0,38 +1,60%
KPN 3,741 +0,06 +1,52%
Flow Traders 17,690 +0,26 +1,49%
TomTom 5,115 +0,07 +1,39%
Vopak 42,120 +0,56 +1,35%
ArcelorMittal 20,280 +0,26 +1,30%
ING 16,288 +0,20 +1,27%
NSI 20,400 +0,25 +1,24%
RANDSTAD NV 43,420 +0,53 +1,24%
Corbion 23,780 +0,28 +1,19%
Basic-Fit 22,400 +0,26 +1,17%
Eurocommercial Properties 24,100 +0,25 +1,05%
Van Lanschot Kempen NV 40,900 +0,40 +0,99%
ALLFUNDS GROUP 5,255 +0,05 +0,96%
Akzo Nobel 57,940 +0,54 +0,94%
WDP 24,380 +0,22 +0,91%
ForFarmers 3,160 +0,03 +0,80%
Philips Koninklijke 27,200 +0,19 +0,70%
Wereldhave 14,320 +0,10 +0,70%
Brunel 8,960 +0,06 +0,67%
B&S Group SA 4,650 +0,03 +0,65%
AMX 891,63 +5,55 +0,63%
AMG Critical Materials N.V. 14,190 +0,08 +0,57%
Heineken 81,960 +0,46 +0,56%
PROSUS 33,505 +0,16 +0,46%
ASCX 1.190,04 +4,78 +0,40%
Pharming 0,684 +0,00 +0,37%
Ahold Delhaize 31,270 +0,07 +0,22%
TKH 36,720 +0,08 +0,22%
BAM 3,692 +0,01 +0,22%
Fagron 19,120 +0,04 +0,21%
ACOMO 17,420 0,00 0,00%
CM.COM 6,300 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
BESI 107,250 -3,55 -3,20%
RELX 40,980 -1,20 -2,84%
Wolters Kluwer 149,800 -3,70 -2,41%
SBM Offshore 16,140 -0,36 -2,18%
UMG 22,850 -0,48 -2,06%
ADYEN NV 1.266,600 -24,60 -1,91%
INPOST 16,110 -0,31 -1,89%
Avantium 1,796 -0,03 -1,86%
Fugro 20,900 -0,36 -1,69%
HEIJMANS KON 24,150 -0,40 -1,63%
ASMI 547,200 -8,20 -1,48%
IMCD 149,350 -2,10 -1,39%
NX FILTRATION 4,805 -0,07 -1,33%
Vastned 24,250 -0,30 -1,22%
ASML 727,500 -8,90 -1,21%
THEON INTERNAT 10,560 -0,08 -0,75%
Arcadis 64,250 -0,40 -0,62%
AEX 892,56 -4,42 -0,49%
Galapagos 25,740 -0,12 -0,46%
AALBERTS NV 34,560 -0,16 -0,46%
EXOR NV 98,550 -0,45 -0,45%
RENEWI 7,690 -0,03 -0,39%
Nedap N.V. 57,000 -0,20 -0,35%
SHELL PLC 30,935 -0,07 -0,23%
OCI 28,820 -0,06 -0,21%
UNILEVER PLC 58,740 -0,12 -0,20%
Sligro 12,760 -0,02 -0,16%
DSM FIRMENICH AG 120,000 -0,15 -0,12%
Alfen N.V. 13,210 -0,01 -0,08%
vlag naam koers verschil relatief verschil
AEX 891,85 -5,13 -0,57%
AEX GR 3.486,82 -18,31 -0,52%
Germany40^ 18.628,60 +36,75 +0,20%
FTSE 100 8.258,00 -11,60 -0,14%
EURO50 4.833,69 -9,55 -0,20%
US30^ 41.013,20 +62,50 +0,15%
Nasd100^ 18.902,00 -17,30 -0,09%
US500^ 5.522,27 +5,31 +0,10%
Japan225^ 36.763,60 +41,30 +0,11%
VD-NEW 17,66 +1,45 +8,97%
#/^ Index indications calculated real time, zie disclaimer